| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-16 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 7e-12 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 1e-07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-07 |